Company facts
- Industry
- Blank Checks
- Headquarters
- New York, New York
- Most recent report
- 10-Q, filed Aug 14, 2026
- Filings on record
- 76 filings
- On EDGAR
- CIK 2028614
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 7
News 8 of 13
Prospectuses and Registrations 8 of 10
- 424B4 Final prospectus for an offering Jan 29, 2025
- POS AM Post-effective amendment to a registration Jan 22, 2025
- POS AM Post-effective amendment to a registration Jan 14, 2025
- S-1/A Registration statement for an offering, amended Jan 6, 2025
- S-1/A Registration statement for an offering, amended Dec 9, 2024
- S-1/A Registration statement for an offering, amended Nov 25, 2024
- S-1/A Registration statement for an offering, amended Nov 7, 2024
- S-1/A Registration statement for an offering, amended Sep 27, 2024
Proxies 3
Ownership 8 of 28
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 26, 2026
- SCHEDULE 13G Large holder reported a passive stake May 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 12, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2025
Other 8 of 15
- 425 Jul 20, 2026
- 425 May 5, 2026
- NT 10-K Notice that an annual report will be late Apr 1, 2026
- NT 10-Q Notice that a quarterly report will be late Nov 17, 2025
- NT 10-Q Notice that a quarterly report will be late May 15, 2025
- EFFECT Notice that a registration became effective Jan 27, 2025
- CORRESP Reply to SEC staff Jan 23, 2025
- CORRESP Reply to SEC staff Jan 23, 2025
Everything here comes from Drugs Made In America Acquisition Corp.'s own filings on SEC EDGAR. The filing list is rechecked every hour.